抗PD-1 MAb市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00023269
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

市場概要 免疫システムには、体内の正常な細胞と「異物」とみなされる細胞を区別する重要な機能があります。これは、免疫システムが「チェックポイント」を使用して正常な細胞を傷つけることなく外来細胞を攻撃するのに役立ちます。免疫チェックポイントは、免疫応答を開始するために活性化(または不活性化)する必要がある特定の免疫細胞上の分子です。がん細胞はこれらのチェックポイントを使用して、がん細胞に対する免疫系の攻撃を回避します。これらのチェックポイントを標的とする特定の薬剤はチェックポイント阻害剤と呼ばれます。これらの薬剤は、細胞表面チェックポイントタンパク質を標的として、免疫系によるがん細胞の認識と破壊を刺激します。 PD-1 は、T 細胞と呼ばれる免疫細胞上のチェックポイント タンパク質です。プログラム細胞死タンパク質 1 (PD-1) 阻害剤は、細胞の表面に存在する PD-1 免疫チェックポイントタンパク質の活性をブロックするチェックポイント阻害剤抗がん剤のグループです。抗 PD-1 モノクローナル抗体は PD-1 受容体をブロックするため、T 細胞は阻害されなくなり、腫瘍に対する免疫応答を活性化します。 市場範囲 「2031 年までの世界の抗 PD-1 MAb 市場分析」は、世界市場の傾向分析に特に焦点を当てたヘルスケア業界の専門的で詳細な調査です。このレポートは、製品、アプリケーション、および地域ごとの詳細な市場分割とともに、抗PD-1 MAb市場の概要を提供することを目的としています。このレポートは、主要な抗PD-1 MAb市場プレーヤーの市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。 市場セグメンテーション
    • 製品に基づいて、世界の抗 PD-1 MAb 市場は 40mg、100mg、200mg などに分類されます。 • アプリケーションに基づいて、市場は黒色腫患者、肺がん患者、リンパ腫患者などに分かれます。
市場力学 推進要因
    • がんの罹患率の増加とチェックポイント阻害剤に対する意識の高まりが、抗PD-1 MAb市場を推進しています。 • ペムブロリズマブとニボルマブの採用の増加と高齢者人口の増加が市場の成長を押し上げています。 • がんのスクリーニング手順における技術の進歩、医療費の増加、がんを緩和するための政府の取り組みの拡大が市場の成長を促進しています。
制約
    • 研究活動に伴う高額な費用。
このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南米。各地域別の抗 PD-1 MAb 市場は、後でそれぞれの国およびセグメントごとにサブセグメント化されます。このレポートでは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会について取り上げています。レポートは、需要と供給の両方の側面から市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、および南米のこれらの地域の抗PD-1 MAb市場に影響を与える政治的、経済的、社会的および技術的要因を評価した後。抗PD-1 MAB 市場に対する新型コロナウイルス感染症(COVID-19) の影響 新型コロナウイルス感染症(COVID-19)は、2021 年 12 月に初めて武漢(中国)で発生し、それ以来、速いペースで世界中に広がりました。米国、インド、ブラジル、ロシア、フランス、英国、トルコ、イタリア、スペインは、確認された感染者数と報告された死亡者数の点で最も深刻な影響を受けている国の一部です。新型コロナウイルス感染症は、ロックダウン、渡航禁止、事業停止などにより、さまざまな国の経済や産業に影響を与えています。がん患者は、新型コロナウイルス感染症の高リスクグループと考えられています。さらに、感染患者の隔離、予防、治療に関する医療業界の負担が増大したため、待機的手術が延期される結果となった。したがって、がん患者にとっての最も重大なリスクは、構造、ツール、医療専門家などのすべての病院リソースが発生管理に専念しているため、通常は高レベルの医療サービスが利用できないことです。したがって、上記の要因は、このパンデミック中の市場の成長に広く影響を与えました。 市場関係者 このレポートでは、有機的および無機的な成長戦略として抗 PD-1 MAb 市場の主要な展開について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略活動は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。抗PD-1 MAb市場のプレーヤーは、世界市場における抗PD-1 MAbの需要の高まりに伴い、将来的に有利な成長機会を得ることが期待されています。レポートには、抗PD-1 MAb市場における主要企業のSWOT分析および市場戦略とともにプロフィールも含まれています。さらに、このレポートは業界の主要企業に焦点を当てており、企業概要、提供されるコンポーネント、サービス、過去 3 年間の財務情報、過去 5 年間の主要な開発などの情報を提供します。
    • Merck • Junshi Pharma • Coherus BioSciences • Bristol Myers Squibb • TopAlliance Biosciences Co., Ltd. • Selleck Chemicals • Aditya Pharma • Beijingbeine •  ;Genentech • Innovent Biologics Inc
Insight Partner の専任の研究分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成され、既存の研究にさまざまなカスタマイズ オプションを提供します。
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the prominent players in Anti-PD1 Mab Market?

Merck, Junshi Pharma,Cohereus Biosciences, Aditya Pharma, Genetech,Bristols Meyers Squibb,Top Alliance

Which is the fastest growing region in Anti-PD1 Mab Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)

Which region accounts for highest revenue share Anti-PD1 Mab Market?

North America region accounts for highest revenue share Anti-PD1 Mab Market

What years does this Anti-PD1 Mab Market include?

The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)

At what CAGR the Anti-PD1 Mab Market projected to grow?

The market is expected to grow at a CAGR of 9.6%

Major driver boosting the Anti-PD1 Mab Market growth?

Rising cancer cases is the major factors boosting the Anti-PD1 Mab Market growth

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1.Merck
2.Junshi Pharma
3.Coherus BioSciences
4.Bristol Myers Squibb
5.TopAlliance Biosciences Co., Ltd.
6.Selleck Chemicals
7.Aditya Pharma
8.Beijing Beigene
9.Genentech
10.Innovent Biologics Inc

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.